CONSOLIS SYSTEMS LIMITED
Company number 06380980 · Monitor this company
This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.
Financial Health Assessment: CONSOLIS SYSTEMS LIMITED
1. Financial Health Score: D-
This company is exhibiting critical symptoms of financial distress. While it remains technically operational, the balance sheet reveals a deeply insolvent business that is entirely dependent on external group support to continue functioning. The patient is on life support — surviving only because the "family" (parent company) is keeping the ventilator running.
2. Key Vital Signs
| Vital Sign | 2024 | 2023 | Interpretation |
|---|---|---|---|
| Net Assets | -£692,491 | -£693,053 | ⚠️ Critical — Liabilities exceed assets by nearly £700k |
| Shareholders' Funds | -£4,972,491 | -£4,973,053 | ⚠️ Critical — Accumulated losses approaching £5M |
| Cash Position | £30,659 | £3,638 | 📈 Improving — Significant cash recovery, though from a critically low base |
| Current Liabilities | £720,765 | £689,229 | ⚠️ Deteriorating — Debts growing, now over 23x cash holdings |
| Working Capital | -£690,106 | -£685,591 | ⚠️ Critical — Massive shortfall in short-term liquidity |
| Employees | 0 | 0 | ❗ Unusual — No staff on payroll |
| Fixed Assets | £0 | £0 | ⚠️ Stripped — All assets fully depreciated/amortised |
Historical Trend Analysis
The financial trajectory tells a concerning story:
- 2015: The last year of positive health — net assets of £303,131
- 2016: Cardiac event — net assets plummet to -£89,397; P&L reserves crash to -£4,369,397 (suggesting a major write-off or impairment)
- 2017-2024: Chronic condition — the company has bled losses consistently, with shareholders' funds deteriorating from -£5.05M to -£4.97M
The slight improvement in 2024 shareholders' funds (£562 better than 2023) is the faintest pulse of recovery — but barely registers against the scale of accumulated damage.
3. Diagnosis
Primary Conditions
1. Balance Sheet Insolvency (Severe) The company is insolvent by a substantial margin. Net liabilities of £692,491 mean the business cannot cover its debts even if all assets were liquidated immediately. This is the financial equivalent of a patient whose organs cannot sustain life without intervention.
2. Extreme Liquidity Crisis (Critical) With only £30,659 in cash against £720,765 in current liabilities, the company has a current ratio of approximately 0.04 — meaning it can cover roughly 4p for every £1 owed within the next year. A healthy ratio is typically 1.5-2.0.
3. Dependency on Group Support (Chronic) The balance sheet reveals: - £35,764 owed to group undertakings (up from £4,229 in 2023) - £680,000 in "other creditors" — which appears to be inter-company or director-related debt - The parent company, It's Lolly Limited, owns more than 75% of shares
This is a patient surviving on a transfusion from the parent company. Without that support, the business would face immediate insolvency proceedings.
4. Operational Hollowing (Concerning) Zero employees, zero fixed assets, and fully amortised intangible assets suggest this company has been stripped down to a shell. It may now serve primarily as an intellectual property holder or financing vehicle within the Lolly group structure.
What the Numbers Reveal About Business Health
The company appears to have undergone a significant restructuring around 2016, when the massive P&L reserve deficit appeared. Since then, it has operated in a zombie-like state — technically alive but without the resources to thrive independently. The recent increase in amounts owed to group undertakings (from £4,229 to £35,764) suggests the parent is increasing its financial support, which could indicate either: - Investment in a turnaround strategy, or - Ongoing subsidy of losses
4. Recommendations
Immediate Actions (Urgent Care)
-
Formalise Group Support: The directors' going concern assertion relies on group support. This should be documented through a formal letter of support or comfort letter from It's Lolly Limited, confirming continued financial backing for at least 12 months.
-
Debt Restructuring: The £680,000 in "other creditors" (likely inter-company) should be evaluated for conversion to equity or long-term subordinated loans to improve the balance sheet presentation and reduce the apparent insolvency.
-
Cash Flow Forecasting: With current liabilities 23x cash reserves, the company needs robust 13-week cash flow forecasting to ensure it can meet obligations as they fall due.
Medium-Term Actions (Rehabilitation)
-
Strategic Review: Clarify the purpose of Consolis Systems within the Lolly group. If it holds intellectual property, this should be properly valued and monetised. If it's a financing vehicle, consider merger with the parent to eliminate duplicated costs.
-
Revenue Generation Assessment: The accounts provide no turnover figure (small company exemption), but with zero employees and no visible trading assets, stakeholders should question whether this entity is generating any independent revenue.
-
Capital Reduction: Consider a court-approved reduction of capital to eliminate the accumulated P&L deficit, making the balance sheet more presentable if the company needs to enter into contracts or relationships where financial health is scrutinised.
Long-Term Actions (Preventive Care)
-
Consider Voluntary Dissolution: If this entity serves no independent commercial purpose, the most efficient treatment may be orderly wind-down and dissolution, transferring any valuable assets (IP, contracts) to the parent company.
-
Governance Enhancement: With only two directors and one also serving as secretary, and with the company being effectively controlled by its parent, ensure that conflicts of interest are properly managed and that the company maintains sufficient independence in its decision-making.
Risk Assessment
| Risk Factor | Likelihood | Impact | Overall Risk |
|---|---|---|---|
| Insolvency proceedings if group support withdrawn | Medium | Very High | Critical |
| Inability to pay debts as they fall due | High | Very High | Critical |
| Regulatory scrutiny of going concern basis | Medium | High | High |
| Director liability for wrongful trading | Medium | Very High | Critical |
Prognosis
Short-term (0-12 months): The company will likely continue operating with group support. The improved cash position suggests recent investment, but the structural insolvency remains unaddressed. Survival is probable but entirely dependent on parent company willingness to continue funding.
Medium-term (1-3 years): Without significant restructuring — either through debt-for-equity swaps, capital reduction, or merger with the parent — this company will remain in a permanently insolvent state. The gradual deterioration in shareholders' funds suggests ongoing losses that will continue to erode the position.
Long-term: The most likely outcome is either absorption into the parent company or eventual dissolution once the group structure is rationalised. There is no visible pathway to independent financial health.